News
April 28, 2025
TScan Therapeutics Announces Upcoming Presentation at the American Society of Gene and Cell Therapy 28th Annual Meeting
March 31, 2025
TScan Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
March 27, 2025
TScan Therapeutics Appoints Commercial Leader Stephen Camiolo as Senior Vice President, Market Access
March 5, 2025
TScan Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
February 27, 2025
TScan Therapeutics Announces Upcoming Presentation at the TD Cowen 45th Annual Health Care Conference
February 18, 2025
TScan Therapeutics to Participate in the H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference
December 26, 2024
TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium
December 23, 2024
TScan Therapeutics Refinances Existing Convertible Debt Facility with Term Loan for up to $52.5 Million from Silicon Valley Bank
December 9, 2024
TScan Therapeutics to Present Updated Data from the Ongoing ALLOHA™ Phase 1 Heme Trial During Oral Session at the 66th American Society of Hematology Annual Meeting and Exposition
December 5, 2024